Skip to main content
SpringerLink
Log in

New Medication Guide developed for naltrexone

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA.Important change to the patient package insert for VIVITROL (Rm) (naltrexone for extended-release injectable suspension) - new medication guide. Internet Document: [2 pages], Apr 2010. Available from: URL: http://www.fda.gov

  2. FDA.VIVITROL (Rm) (naltrexone for extended-release injectable suspension. Internet Document: [5 pages], Dec 2009. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

New Medication Guide developed for naltrexone. React. Wkly. 1301, 4 (2010). https://doi.org/10.2165/00128415-201013010-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013010-00009

Keywords

Search

Navigation